BridgeMD
New treatment option for Sepsis
Official title Lactate Kinetics in Septic Shock
ClinicalTrials.gov ID: NCT05349370
What this study is testing
- What it's testing
- Lactate kinetics will be studied in hospitalized septic patients using a bolus injection of stable isotopically labeled lactate.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Sepsis
- Age \>17 years
- Arterial catheter
- Lactate \> 2 mmol at any time point prior to inclusion
You likely can't join if
- Mitochondrial defect
- Degenerative muscle disease
- Terminal liver failure
The study team makes the final eligibility decision.
Where it's taking place
- Stockholm, Stockholm County, Sweden
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stockholm, Stockholm County, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.